Company Update (NYSE:JNJ): Johnson & Johnson Aligns With HP To Create Personalized Healthcare Solutions
May 17, 2016 at 10:18 AM EDT
[Benzinga] – Johnson & Johnson (NYSE: JNJ ) revealed that its subsidiary and HP Inc. (NYSE: HPQ ) subsidiary aligned to create personalized healthcare solution with the help of 3D printing technologies. According to … Read more on this. Johnson & Johnson (JNJ) , valued at $313.82B, began trading this morning at $114.54. A quick look at the market, the company’s stock traded between $113.62 and $114.56 with the price of the stock fluctuating between $81.79 to $115.00 over the last 52 weeks. JNJ shares are currently priced at 17.31x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 5.38x forward p/e ratio. And for dividend hunters, the company pays shareholders $3.20 per share annually in dividends, yielding 2.82%. Consensus earnings for the current quarter by the 19 sell-side analysts covering the stock is an estimate of $1.69 per share, which would be $0.02 worse than the year-ago quarter and a $0.03 sequential increase. Furthermore, our analysis shows the full-year EPS estimate to be $6.61, which would be a $0.41 improvement when compared to the last year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $17.98 Billion. If reported, that would be a 1.07% increase over the year-ago quarter. In terms of ratings, Goldman upgraded JNJ from Sell to Neutral (Mar 14, 2016). Previously, Barclays downgraded JNJ from Overweight to Equal Weight. Given all the information above, we should disclose to readers that the average price target is $117.44, which is 2.53% above than it opened this morning. See more in (NYSE:JNJ) Similar Articles: Stock Update (NYSE:HPQ): Johnson & Johnson Aligns With HP To Create Personalized Healthcare Solutions Company Update: Johnson & Johnson (NYSE:JNJ) – Jim Cramer’s Top Takeaways: Oracle, Johnson & Johnson Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Participate in Barclays Global Healthcare Conference
